AIT Featured Posts $90 Million Injected into Drug Discovery Company BenevolentAI; Focus Shifts to Making Medicines… Sudipto Ghosh Sep 23, 2019 BenevolentAI applies its technology designed to enable better data-driven decisions to find ways to treat disease and personalize drugs for specific…
Technology BenevolentAI Announces Agreement with Leading Healthcare Company to Leverage BenevolentAI’s… AIT News Desk Sep 5, 2019 Framework Collaboration Agreement with Novartis Across Multiple Drug Programmes BenevolentAI announced that it has signed a Framework Collaboration…
Computing Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics… AIT News Desk Aug 6, 2019 Neuropore Therapies, Inc. announced that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive…